Pulse Biosciences Inc EV/EBITDA
What is the EV/EBITDA of Pulse Biosciences Inc?
The EV/EBITDA of Pulse Biosciences Inc is N/A
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Health Care sector on NASDAQ compared to Pulse Biosciences Inc
What does Pulse Biosciences Inc do?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Companies with ev/ebitda similar to Pulse Biosciences Inc
- Terramin Australia has EV/EBITDA of N/A
- Danakali has EV/EBITDA of N/A
- Prospect Park Capital has EV/EBITDA of N/A
- Altura Mining has EV/EBITDA of N/A
- Redstar Gold has EV/EBITDA of N/A
- Aminex Plc has EV/EBITDA of N/A
- Pulse Biosciences Inc has EV/EBITDA of N/A
- Nova Cannabis has EV/EBITDA of N/A
- GT Gold has EV/EBITDA of N/A
- Nanoxplore Inc has EV/EBITDA of N/A
- Cervantes has EV/EBITDA of N/A
- SolGold Plc has EV/EBITDA of N/A
- Sailfish Royalty has EV/EBITDA of N/A